231 related articles for article (PubMed ID: 2468713)
1. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
Weinhold KJ; Lyerly HK; Stanley SD; Austin AA; Matthews TJ; Bolognesi DP
J Immunol; 1989 May; 142(9):3091-7. PubMed ID: 2468713
[TBL] [Abstract][Full Text] [Related]
2. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism.
Liu AY; Miskovsky EP; Stanhope PE; Siliciano RF
J Immunol; 1992 Jun; 148(12):3789-98. PubMed ID: 1351088
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
[TBL] [Abstract][Full Text] [Related]
4. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients.
Amadori A; De Silvestro G; Zamarchi R; Veronese ML; Mazza MR; Schiavo G; Panozzo M; De Rossi A; Ometto L; Mous J
J Immunol; 1992 May; 148(9):2709-16. PubMed ID: 1374095
[TBL] [Abstract][Full Text] [Related]
5. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis.
Mann DL; Lasane F; Popovic M; Arthur LO; Robey WG; Blattner WA; Newman MJ
J Immunol; 1987 Apr; 138(8):2640-4. PubMed ID: 3031162
[TBL] [Abstract][Full Text] [Related]
6. Recognition of HIV glycoprotein gp120 by T cells. Role of monocyte CD4 in the presentation of gp120.
Siliciano RF; Knall C; Lawton T; Berman P; Gregory T; Reinherz EL
J Immunol; 1989 Mar; 142(5):1506-11. PubMed ID: 2537355
[TBL] [Abstract][Full Text] [Related]
7. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
Capobianchi MR
J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
[TBL] [Abstract][Full Text] [Related]
8. HIV infection is blocked in vitro by recombinant soluble CD4.
Fisher RA; Bertonis JM; Meier W; Johnson VA; Costopoulos DS; Liu T; Tizard R; Walker BD; Hirsch MS; Schooley RT
Nature; 1988 Jan; 331(6151):76-8. PubMed ID: 2829022
[TBL] [Abstract][Full Text] [Related]
9. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
[TBL] [Abstract][Full Text] [Related]
10. Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.
Krowka J; Stites D; Mills J; Hollander H; McHugh T; Busch M; Wilhelm L; Blackwood L
Clin Exp Immunol; 1988 May; 72(2):179-85. PubMed ID: 2842093
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
Traunecker A; Lüke W; Karjalainen K
Nature; 1988 Jan; 331(6151):84-6. PubMed ID: 2829024
[TBL] [Abstract][Full Text] [Related]
12. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte activation by HIV-1 envelope glycoprotein.
Kornfeld H; Cruikshank WW; Pyle SW; Berman JS; Center DM
Nature; 1988 Sep; 335(6189):445-8. PubMed ID: 2843775
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
Farrar WL; Harel-Bellan A; Ferris DK
Crit Rev Immunol; 1988; 8(4):315-39. PubMed ID: 2850890
[TBL] [Abstract][Full Text] [Related]
15. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
Ahmad A; Ladha A; Cohen EA; Menezes J
Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
[TBL] [Abstract][Full Text] [Related]
16. Immunotoxicity of AZT: inhibitory effect on thymocyte differentiation and peripheral T cell responsiveness to gp120 of human immunodeficiency virus.
McKallip RJ; Nagarkatti M; Nagarkatti PS
Toxicol Appl Pharmacol; 1995 Mar; 131(1):53-62. PubMed ID: 7878678
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CD4+ T cell function by the HIV envelope protein, gp120.
Diamond DC; Sleckman BP; Gregory T; Lasky LA; Greenstein JL; Burakoff SJ
J Immunol; 1988 Dec; 141(11):3715-7. PubMed ID: 2846691
[TBL] [Abstract][Full Text] [Related]
18. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
Hussey RE; Richardson NE; Kowalski M; Brown NR; Chang HC; Siliciano RF; Dorfman T; Walker B; Sodroski J; Reinherz EL
Nature; 1988 Jan; 331(6151):78-81. PubMed ID: 2829023
[TBL] [Abstract][Full Text] [Related]
19. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
20. Shared antigenic epitopes on the V3 loop of HIV-1 gp120 and proteins on activated human T cells.
Trujillo JR; Rogers RA; Brain JD
Virology; 1998 Jun; 246(1):53-62. PubMed ID: 9656993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
